Price | 1W % | 1M % | 3M % | 6M % | 1Y % | YTD % |
|---|---|---|---|---|---|---|
-- | -- | -- | -- | -- | -- | -- |
AI Generated Qualitative Analysis
Your time is precious, so save it. Use AI to get the most important information from the business.
Learn about AmerisourceBergen Corporation
AmerisourceBergen Corporation News
AmerisourceBergen Corporation Quantitative Score
About AmerisourceBergen Corporation
AmerisourceBergen Corporation sources and distributes pharmaceutical products in the United States and internationally. Its Pharmaceutical Distribution segment distributes brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to various healthcare providers, including acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers. It also provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; and packaging solutions to various institutional and retail healthcare providers. In addition, this segment distributes plasma and other blood products, injectable pharmaceuticals, vaccines, and other specialty products; provides other services primarily to physicians who specialize in various disease states, primarily oncology, as well as to other healthcare providers, including hospitals and dialysis clinics; and offers data analytics, outcomes research, and additional services for biotechnology and pharmaceutical manufacturers. The company's Other segment provides integrated manufacturer services, such as clinical trial support, product post-approval, and commercialization support; specialty transportation and logistics services for the biopharmaceutical industry; and sells pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and various other products to customers in the companion animal and production animal markets, as well as demand-creating sales force services to manufacturers. AmerisourceBergen Corporation was incorporated in 2001 and is headquartered in Conshohocken, Pennsylvania.
AmerisourceBergen Corporation Earnings & Revenue
AmerisourceBergen Corporation Financials
Table Compare
Compare ABC metrics with: | |||
|---|---|---|---|
Earnings & Growth | ABC | None | |
EPS (TTM) YoY Growth | -- | -- | |
Revenue (TTM) YoY Growth | -- | -- | |
Valuation (TTM) | ABC | None | |
Price/Earnings Ratio | -- | -- | |
Price/Sales Ratio | -- | -- | |
Profitability & Efficiency (TTM) | ABC | None | |
Net Profit Margin | -- | -- | |
Return on Equity | -- | -- | |
Financial Health (TTM) | ABC | None | |
Debt/Assets Ratio | -- | -- | |
Assets/Liabilities Ratio | -- | -- | |
AmerisourceBergen Corporation Income
AmerisourceBergen Corporation Balance Sheet
AmerisourceBergen Corporation Cash Flow
AmerisourceBergen Corporation Financials Over Time
Analysts Rating
Strong Buy
Buy
Hold
Sell
Strong Sell
Metrics Scores
| Metrics | Score |
|---|---|
| Discounted Cash Flows | Buy |
| Return on Equity | Strong Buy |
| Return on Assets | Buy |
| Debt/Equity Ratio | Strong Buy |
| Price/Earnings Ratio | Strong Buy |
| Price/Book Ratio | Strong Buy |
Price Targets
Disclaimer: This 3rd party analysis information is for reference only and does not constitute investment advice.
AmerisourceBergen Corporation Dividends
| Yield (TTM) | Dividend (TTM) | |
|---|---|---|
Infinity% | 1.9400 |
| Payment Date | Dividend | Frequency |
|---|---|---|
| 2023-08-28 | 0.485 | Quarterly |
| 2023-05-30 | 0.485 | Quarterly |
| 2023-02-27 | 0.485 | Quarterly |
| 2022-11-28 | 0.485 | Quarterly |
| 2022-08-29 | 0.46 | Quarterly |
AmerisourceBergen Corporation Valuation
Project future cash flows and get the intrinsic value per share.
Historical Market Cap
Shares Outstanding
AmerisourceBergen Corporation Executives
| Name | Role |
|---|---|
| Mr. Steven H. Collis | Chairman, Pres & Chief Executive Officer |
| Dr. Robert P. Mauch Ph.D., PharmD | Executive Vice President & Chief Operating Officer |
| Mr. James F. Cleary Jr. | Executive Vice President & Chief Financial Officer |
| Ms. Gina K. Clark | Executive Vice President and Chief Communications & Admin. Officer |
| Ms. Silvana Battaglia | Executive Vice President & Chief HR Officer |
| Name | Role | Gender | Date of Birth | Pay |
|---|---|---|---|---|
| Mr. Steven H. Collis | Chairman, Pres & Chief Executive Officer | Male | 1961 | 5.49M |
| Dr. Robert P. Mauch Ph.D., PharmD | Executive Vice President & Chief Operating Officer | 1967 | 2.32M | |
| Mr. James F. Cleary Jr. | Executive Vice President & Chief Financial Officer | Male | 1963 | 2.12M |
| Ms. Gina K. Clark | Executive Vice President and Chief Communications & Admin. Officer | Female | 1957 | 1.68M |
| Ms. Silvana Battaglia | Executive Vice President & Chief HR Officer | Female | 1968 | 1.58M |
AmerisourceBergen Corporation Insider Trades
| Date | 15 Jan |
| Name | GREENBERG LON R |
| Role | Director |
| Transaction | Acquired |
| Type | M-Exempt |
| Shares | 1340 |
| Date | 4 Jan |
| Name | Battaglia Silvana |
| Role | Executive Vice President |
| Transaction | Acquired |
| Type | A-Award |
| Shares | 52.986 |
| Date | 4 Jan |
| Name | Campbell Elizabeth S |
| Role | Executive Vice President |
| Transaction | Acquired |
| Type | A-Award |
| Shares | 57.569 |
| Date | 4 Jan |
| Name | Donato Leslie E |
| Role | EVP & Chief Strategy Officer |
| Transaction | Acquired |
| Type | A-Award |
| Shares | 40.097 |
| Date | 3 Jan |
| Name | Krikorian Lazarus |
| Role | SVP & Chief Accounting Officer |
| Transaction | Acquired |
| Type | M-Exempt |
| Shares | 252 |
| Date | Name | Role | Transaction | Type | Shares |
|---|---|---|---|---|---|
| 15 Jan | GREENBERG LON R | Director | Acquired | M-Exempt | 1340 |
| 4 Jan | Battaglia Silvana | Executive Vice President | Acquired | A-Award | 52.986 |
| 4 Jan | Campbell Elizabeth S | Executive Vice President | Acquired | A-Award | 57.569 |
| 4 Jan | Donato Leslie E | EVP & Chief Strategy Officer | Acquired | A-Award | 40.097 |
| 3 Jan | Krikorian Lazarus | SVP & Chief Accounting Officer | Acquired | M-Exempt | 252 |